Gateway 2012: Gemü Valves - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Gemü Valves


Gemü Valves
3800 Camp Creek Parkway
Bldg 2600 Ste 120
Atlanta, GA 30331
www.gemu.com
info@gemu.com
Telephone: 678-553-3400
Fax: 404-344-4003

Company Description:

Gemü Valves, an ISO9001 certified company, is a leading world-wide manufacturer of high quality valves, measurement and controls systems. The Gemü product line includes Diaphragm, Globe, Angle Seat and PFA, PVDF and Polypropylene valves, as well as, Measurement and Control Systems. With an unparalleled vision of excellent customer service, Gemü serves the Pharmaceutical, Microelectronics, Semiconductor, Food and Beverage, Chemical, Mining and Metal Extraction, and Water/Waste Water Treatment Industries. Gemü’s ground breaking design and leading edge manufacturing technology provides engineered solutions to complex process challenges. Gemü’s overriding philosophy is to ensure that each and every customer contact is a quality experience.

Stop by booth 3612 at Interphex New York to see Gemü’s products. The 4242 Combi Switchbox offers unprecedented reliability and repeatability and features a highly visible glowtop indicator and local and remote programming along with local and remote diagnostics.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here